No­var­tis cuts 275 jobs at Illi­nois site to con­sol­i­date Zol­gens­ma man­u­fac­tur­ing in North Car­oli­na

As No­var­tis con­tin­ues to re­shape it­self, the com­pa­ny is shut­ting the doors to one of its gene ther­a­py man­u­fac­tur­ing sites in the US.

The clo­sure …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.